Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 83
Filtrar
2.
Brain Res Bull ; 212: 110952, 2024 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-38636611

RESUMEN

Anxiety is a prevalent mental illness known for its high incidence, comorbidity, and tendency to recur, posing significant societal and individual burdens. Studies have highlighted Interleukin-19 (IL-19) as having potential relevance in neuropsychiatric disorders. Our previous research revealed that IL-19 overexpression in colonies exacerbated anxiety-related behaviors induced by dextran sodium sulfate/stress. However, the precise role and molecular mechanisms of IL-19 in anxiety regulation remain uncertain. In this study, we initiated an acute restraint stress (ARS)-induced anxious mouse model and identified heightened expression of IL-19 and IL-20Rα in the medial prefrontal cortex (mPFC) of ARS mice. Notably, IL-19 and IL-20Rα were predominantly present in the excitatory pyramidal neurons of the mPFC under both basal and ARS conditions. Utilizing the adeno-associated virus (AAV) strategy, we demonstrated that IL-19 overexpression in the mPFC induced anxiety-related behaviors and elevated stress susceptibility. Additionally, we observed decreased protein levels of brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95) in the mPFC of IL-19 overexpression mice, accompanied by reduced phosphorylation of in the p38, JNK, and Erk signaling pathways. These findings emphasize the role of IL-19 in modulating anxiety-related behaviors within the mPFC and suggest its potential as a pathological gene and therapeutic target for anxiety.

3.
Respir Res ; 25(1): 134, 2024 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-38500102

RESUMEN

Neu1 is a sialidase enzyme that plays a crucial role in the regulation of glycosylation in a variety of cellular processes, including cellular signaling and inflammation. In recent years, numerous evidence has suggested that human NEU1 is also involved in the pathogenesis of various respiratory diseases, including lung infection, chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis. This review paper aims to provide an overview of the current research on human NEU1 and respiratory diseases.


Asunto(s)
Asma , Trastornos Respiratorios , Humanos , Neuraminidasa/genética , Inflamación
4.
Phytomedicine ; 126: 155283, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38422652

RESUMEN

BACKGROUND: Portulacae Herba and Granati Pericarpium pair (PGP) is a traditional Chinese herbal medicine treatment for colitis, clinically demonstrating a relatively favorable effect on relieving diarrhea and abnormal stools. However, the underlying mechanism remain uncertain. PURPOSE: The present study intends to evaluate the efficacy of PGP in treating colitis in mice and investigate its underlying mechanism. METHODS: The protective effect of PGP against colitis was determined by monitoring body weight, colon length, colon weight, and survival rate in mice. Colonic inflammation was assessed by serum cytokine levels, colonic H&E staining, and local neutrophil infiltration. The reversal of intestinal epithelial barrier damage by PGP was subsequently analyzed with Western blot and histological staining. Furthermore, RNA-seq analysis and molecular docking were performed to identify potential pathways recruited by PGP. Following the hints of the transcriptomic results, the role of PGP through the IL-6/STAT3/SOCS3 pathway in DSS-induced colitis mice was verified by Western blot. RESULTS: DSS-induced colitis in mice was significantly curbed by PGP treatment. PGP treatment significantly mitigated DSS-induced colitis in mice, as evidenced by improvements in body weight, DAI severity, survival rate, and inflammatory cytokines levels in serum and colon. Moreover, PGP treatment up-regulated the level of Slc26a3, thereby increasing the expressions of the tight junction/adherens junction proteins ZO-1, occludin and E-cadherin in the colon. RNA-seq analysis revealed that PGP inhibits the IL-6/STAT3/SOCS3 pathway at the transcriptional level. Molecular docking indicated that the major components of PGP could bind tightly to the proteins of IL-6 and SOCS3. Meanwhile, the result of Western blot revealed that the IL-6/STAT3/SOCS3 pathway was inhibited at the protein level after PGP administration. CONCLUSION: PGP could alleviate colonic inflammation and reverse damage to the intestinal epithelial barrier in DSS-induced colitis mice. The underlying mechanism involves the inhibition of the IL-6/STAT3/SOCS3 pathway.


Asunto(s)
Colitis Ulcerosa , Colitis , Extractos Vegetales , Granada (Fruta) , Animales , Ratones , Interleucina-6/metabolismo , Simulación del Acoplamiento Molecular , Colitis/inducido químicamente , Colitis/tratamiento farmacológico , Colitis/metabolismo , Inflamación/metabolismo , Colon/patología , Citocinas/metabolismo , Peso Corporal , Sulfato de Dextran/efectos adversos , Ratones Endogámicos C57BL , Modelos Animales de Enfermedad , Colitis Ulcerosa/tratamiento farmacológico , Transportadores de Sulfato/metabolismo , Transportadores de Sulfato/farmacología , Transportadores de Sulfato/uso terapéutico , Antiportadores/efectos adversos , Antiportadores/metabolismo
5.
Cell Host Microbe ; 32(1): 25-34.e5, 2024 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-38029742

RESUMEN

Emerging SARS-CoV-2 sub-lineages like XBB.1.5, XBB.1.16, EG.5, HK.3 (FLip), and XBB.2.3 and the variant BA.2.86 have recently been identified. Understanding the efficacy of current vaccines on these emerging variants is critical. We evaluate the serum neutralization activities of participants who received COVID-19 inactivated vaccine (CoronaVac), those who received the recently approved tetravalent protein vaccine (SCTV01E), or those who had contracted a breakthrough infection with BA.5/BF.7/XBB virus. Neutralization profiles against a broad panel of 30 sub-lineages reveal that BQ.1.1, CH.1.1, and all the XBB sub-lineages exhibit heightened resistance to neutralization compared to previous variants. However, despite their extra mutations, BA.2.86 and the emerging XBB sub-lineages do not demonstrate significantly increased resistance to neutralization over XBB.1.5. Encouragingly, the SCTV01E booster consistently induces higher neutralizing titers against all these variants than breakthrough infection does. Cellular immunity assays also show that the SCTV01E booster elicits a higher frequency of virus-specific memory B cells. Our findings support the development of multivalent vaccines to combat future variants.


Asunto(s)
Infección Irruptiva , Vacunas contra la COVID-19 , COVID-19 , Inmunización Secundaria , Humanos , COVID-19/prevención & control , SARS-CoV-2/genética , Anticuerpos Neutralizantes , Anticuerpos Antivirales
6.
Pharmacol Res ; 197: 106951, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37804927

RESUMEN

Echinacoside, a natural phenylethanoid glycoside, was discovered and isolated from the garden plant Echinacea angustifolia DC., belonging to the Compositae family, approximately sixty years ago. Extensive investigations have revealed that it possesses a wide array of pharmacologically beneficial activities for human health, particularly notable for its neuroprotective and anticancer activity. Several crucial concerns surfaced, encompassing the recognition of active metabolites that exhibited inadequate bioavailability in their prototype form, the establishment of precise molecular signal pathways or targets associated with the aforementioned effects of echinacoside, and the scarcity of dependable clinical trials. Hence, the question remains unanswered as to whether scientific research can effectively utilize this natural compound. To support future studies on this natural product, it is imperative to provide a systematic overview and insights into potential future prospects. The current review provides a comprehensive analysis of the existing knowledge on echinacoside, encompassing its wide distribution, structural diversity and metabolism, diverse therapeutic applications, and improvement of echinacoside bioavailability for its potential utilization.


Asunto(s)
Asteraceae , Productos Biológicos , Humanos , Glicósidos/farmacología , Glicósidos/uso terapéutico , Disponibilidad Biológica , Productos Biológicos/farmacología , Productos Biológicos/uso terapéutico
9.
Front Pharmacol ; 14: 1160480, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37214441

RESUMEN

Backgrounds: The incidence of melanosis coli (MC) has gradually increased annually, attracting significant attention and efforts into this field. A potential risk for MC is the long-term use of anthraquinone laxatives in patients with constipation. Most traditional cathartic drugs are made from herbs containing anthraquinone compounds. This review aims to provide guidance for the application of traditional Chinese herbs containing anthraquinones for physicians and researchers. Materials and methods: We reviewed risk factors and pathogenesis of MC, and natural anthraquinones isolated from TCM herbs. We searched Pubmed and CNKI databases for literature related to MC with keywords such as"traditional Chinese medicine", "Chinese herbs", "anthraquinones", and "melanosis coli". The literature is current to January 2023 when the searches were last completed. After the literature retrieval, the TCM herbs containing anthraquinones (including component identification and anthraquinone content determination) applied in clinical were selected. According to the collected evidence, we provide a list of herbs containing anthraquinones that could cause MC. Results: We identified 20 herbs belonging to 7 families represented by Polygonaceae, Fabaceae, Rhamnaceae, and Rubiaceae, which may play a role in the pathogenesis of MC. Among these, the herbs most commonly used include Dahuang (Rhei Radix et Rhizome), Heshouwu (Radix Polygoni Multiflori), Huzhang (Rhizoma Polygoni Cuspidati), Juemingzi (Semen Cassiae), Luhui (Aloe) and Qiancao (Rubiae Radix et Rhizoma). Conclusion: Due to a lack of awareness of the chemical composition of TCM herbs, many patients with constipation and even some TCM physicians take cathartic herbal remedies containing abundant anthraquinones to relieve defecation disturbances, resulting in long-term dependence on these herbs, which is potentially associated with most cases of MC. When such treatments are prescribed, TCM physicians should avoid long-term use in large doses to reduce their harm on colonic health. Individuals who take healthcare products containing these herbs should also be under the supervision of a doctor.

10.
ACS Omega ; 8(11): 10160-10175, 2023 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-36969401

RESUMEN

The development of a new and efficient supercritical carbon dioxide (S-CO2) power cycle system is one of the important technical ways to break through the bottleneck of coal power development, improve the efficiency of power generation, and realize energy saving and emission reduction. In order to simplify the complicated workload and save the huge time cost of numerical simulations on combustion characteristics, it is of great significance to accurately make the combustion characteristic prediction according to the operating performance of the S-CO2 CFB boiler. This study proposed a combustion characteristic prediction model corresponding to the S-CO2 CFB boiler based on the adaptive gray wolf optimizer support vector machine (AGWO-SVM). The parameters of the gray wolf optimizer algorithm were processed adaptively first combined with the boiler characteristics, and then the adaptive gray wolf optimizer algorithm was integrated with the support vector machine to solve the imbalance of local and global search problems of particles being easy to gather in a certain position in the process of pattern recognition. The novel method effectively predicts the boiler in the scaling process from the aspect of boiler capacity, optimizes the combustion characteristic expression by numerical simulations, greatly saves time cost and applicability of enlarged design by altering complex numerical simulations, and lays the application foundation of the S-CO2 CFB boiler in the industrial field with acceptable operation accuracy.

11.
Artículo en Inglés | MEDLINE | ID: mdl-36972780

RESUMEN

Methamphetamine (METH) is a highly addictive psychostimulant. The adipocyte-derived hormone adiponectin has a broad spectrum of functions in the brain. However, limited research has been conducted on the effect of adiponectin signaling on METH-induced conditioned place preference (CPP) and knowledge of the underlying neural mechanisms is scarce. The METH induced adult male C57/BL6J mice model were used for testing the therapeutic activities of intraperitoneal injection of AdipoR agonist AdipoRon and peroxisome proliferator-activated receptor gamma (PPARγ)-selective agonist rosiglitazone, adiponectin receptor 1 (AdipoR1) overexpression in hippocampal dentate gyrus (DG), and chemogenetic inhibiting the neural activity of DG, and the changes of neurotrophic factors, synaptic molecules, glutamate receptors, and inflammatory cytokines were also measured. We found that adiponectin expression was significantly reduced in METH addicted patients and mice. Our findings also showed that injection of AdipoRon or rosiglitazone alleviated the METH-induced CPP behavior. Moreover, the expression of AdipoR1 in the hippocampus was also reduced, and AdipoR1 overexpression blocked the development of METH-induced CPP behavior through regulatory effects on neurotrophic factors, synaptic molecules, and glutamate receptors. The observed inhibitory neural activity of the hippocampal dentate gyrus (DG) induced via a chemogenetic approach produced a therapeutic effect on the METH-induced CPP behavior. Finally, we identified an abnormal expression of some key inflammatory cytokines through the PPARγ/Adiponectin/AdipoR1 axis. This study demonstrates that adiponectin signaling is a promising diagnostic and therapeutic target for METH addiction.


Asunto(s)
Estimulantes del Sistema Nervioso Central , Metanfetamina , Masculino , Ratones , Animales , Metanfetamina/farmacología , PPAR gamma/metabolismo , Adiponectina , Rosiglitazona/farmacología , Rosiglitazona/metabolismo , Estimulantes del Sistema Nervioso Central/farmacología , Estimulantes del Sistema Nervioso Central/metabolismo , Hipocampo/metabolismo , Transducción de Señal , Citocinas/metabolismo
12.
Front Oncol ; 13: 1091459, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36761970

RESUMEN

Sintilimab is a fully human IgG4 monoclonal antibody against programmed death-1 (PD-1) used to treat classical Hodgkin's lymphoma and various solid tumors. With increasing use of sintilimab, some rare adverse reactions have been reported. Here, we report a case of a 50-year-old woman with squamous non-small cell lung cancer (NSCLC) (metastasis to pericardium and pleura) who received two cycles of 200 mg sintilimab immunotherapy combined with albumin-bound paclitaxel and carboplatin chemotherapy and one cycle of sintilimab monotherapy. She was diagnosed with Sjogren's syndrome (with symptoms of fever, dry mouth, dysphagia, and eating difficulty) after three cycles' treatment and received standard steroidal therapy. Prior to admission, the patient experienced severe stomach discomfort with vomiting and was hospitalized. Upper gastrointestinal iodine angiography showed significant gastric stenosis as well as lower esophageal stenosis. Subsequent ultrafine gastroscopy revealed ulceration at the stenotic site and an absence of normal peristalsis of the gastric wall. Pathological examination of the lesions showed reactive changes, including ulceration, fibrosis, and inflammatory cell infiltration. After multidisciplinary consultation, it was considered that the patient's gastric stenosis with inflammatory fibrosis changes was due to a sintilimab-induced immune hyperinflammatory reaction. The patient had been treated with standard steroidal therapy since suffering from Sjogren's syndrome, but the gastric stenotic changes were not relieved. The patient then received regular bouginage of esophago-cardiac stenosis under gastroscopy to physically reexpand the fibrous hyperplasia and stenotic site, enabling normal eating function. To our knowledge, this is the first case of gastric stenosis in a patient with squamous NSCLC after using sintilimab and may help clinicians better understand potential immune-related adverse events due to sintilimab and improve assessment and management.

14.
Artículo en Inglés | MEDLINE | ID: mdl-35189797

RESUMEN

BACKGROUND: Wu-Mei-Wan (WMW), a traditional Chinese medicine (TCM) formula, has a good effect on the treatment of obesity and has been proven helpful to promote the metabolism of adipose tissue. However, its underlying mechanism remains to be studied. This study aims to explore the potential pharmacological mechanism of WMW in the treatment of obesity. METHODS: Network pharmacology was used to sort out the relationship between WMW putative targets and obesity-related drug targets or disease targets, which indicated the mechanism of WMW in treating obesity from two aspects of clinical drugs approved by the Food and Drug Administration (FDA) and obesity-related diseases. Databases such as Traditional Chinese Medicine Systems Pharmacology (TCMSP), PubChem, DrugBank, DisGeNET, and Genecards were used to collect information about targets. String platform was used to convert the data into gene symbol of "homo sapiens", and perform gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. With the Human Protein Reference Database (HPRD) as background data, Cytoscape 3.6.0 software was used to construct a new protein-protein interaction (PPI) network. Mechanism diagrams of key pathways were obtained from the KEGG database. AutoDock Vina software was used to conduct molecular docking verification. RESULTS: The number of targets in the overlap between WMW putative targets and obesity-related drug targets accounted for more than 50% of the latter, and HTR3A, SLC6A4, and CYP3A4 were core targets. In obesity-related disease targets-WMW putative targets PPI network, the Th17 cell differentiation pathway, and the IL-17 signaling pathway were key pathways, and the 1st module and the 7th module were central function modules that were highly associated with immunity and inflammation. Molecular docking verified that STAT3, TGFB1, MMP9, AHR, IL1B, and CCL2 were core targets in the treatment of WMW on obesity. CONCLUSION: WMW has similar effects on lipid and drug metabolism as the current obesity-related drugs, and is likely to treat obesity by inhibiting Th17 cell differentiation and alleviating metabolic inflammation.


Asunto(s)
Farmacología en Red , Transducción de Señal , Estados Unidos , Humanos , Simulación del Acoplamiento Molecular , Diferenciación Celular , Bases de Datos de Proteínas , Proteínas de Transporte de Serotonina en la Membrana Plasmática
15.
Rev. bras. med. esporte ; 29: e2022_0613, 2023. tab
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1423366

RESUMEN

ABSTRACT Introduction: Golf is a high-precision sport that requires excellent manual skills and motor coordination. These requirements are essential to determine a player's swing level and, consequently, their sports performance. Objective: Investigate the impact of athletes' body control on golf performance. Methods: To study the three-dimensional motion of golf players in China, the relevant theories and techniques of sports biomechanics were used on 12 golfing volunteers. Real-time sampling correction and analysis were performed using APAS dynamic analysis technology. This paper uses the DLT method to analyze the spatial location of each point three-dimensionally. SPSS15.0 software was used for statistical processing and screening of the results of the tests. Statistics are presented as mean and standard values. Results: The correlation between the golfers' center of gravity in hitting and the rate of motion in the swing was evidenced. The velocity obtained by the racket when hitting the ball is related to the golfer's hip inversion angle. Conclusion: A lower body center of gravity is beneficial to improve golf swing efficiency. Keeping the body in balance is the key to mastering the stroke and acceleration of the racquet. When the athlete performs the reverse pull, the energy they receive also increases, highlighting the need for specific training to promote the athlete's body balance. Level of evidence II; Therapeutic studies - investigation of treatment outcomes.


RESUMO Introdução: O golfe é um esporte de alta precisão que requer excelentes habilidades manuais e coordenação motora. Estes requisitos são essenciais para determinar o nível de balanço de um jogador e, consequentemente, o seu desempenho esportivo. Objetivo: Investigar o impacto do controle corporal dos atletas no desempenho do golfe. Métodos: Para estudar o movimento tridimensional dos jogadores de golfe na China, foram utilizadas as teorias e técnicas relevantes da biomecânica do esporte sobre 12 voluntários praticantes de golfe. A correção e a análise em tempo real da amostragem foram realizadas utilizando a tecnologia de análise dinâmica da APAS. Este artigo usa o método DLT para analisar a localização espacial de cada ponto tridimensionalmente. O programa SPSS15.0 foi usado para processamento estatístico e triagem dos resultados nos testes. As estatísticas são apresentadas como valores médios e padrão. Resultados: A correlação entre o centro de gravidade dos golfistas no acerto e na taxa de movimento no balanço foi evidenciada. A velocidade obtida pela raquete no momento da tacada da bola está relacionada ao ângulo de inversão do quadril do golfista. Conclusão: Um centro de gravidade inferior do corpo é benéfico para melhorar a eficiência da tacada de golfe. Manter o corpo em equilíbrio é a chave para dominar a batida e a aceleração da raquete. Quando o atleta realiza a tração reversa, a energia que ele recebe também aumenta, evidenciando a necessidade de um treinamento específico para promover o equilíbrio corporal do esportista. Nível de evidência II; Estudos terapêuticos - investigação dos resultados do tratamento.


RESUMEN Introducción: El golf es un deporte de alta precisión que requiere excelentes habilidades manuales y coordinación motora. Estos requisitos son esenciales para determinar el nivel de balanceo de un jugador y, en consecuencia, su rendimiento deportivo. Objetivo: Investigar el impacto del control corporal de los atletas en el rendimiento del golf. Métodos: Para estudiar el movimiento tridimensional de los jugadores de golf en China, se utilizaron las teorías y técnicas pertinentes de la biomecánica deportiva en 12 voluntarios golfistas. La corrección y el análisis del muestreo en tiempo real se realizaron mediante la tecnología de análisis dinámico APAS. Este trabajo utiliza el método DLT para analizar la ubicación espacial de cada punto en tres dimensiones. Se utilizó el programa informático SPSS15.0 para el tratamiento estadístico y el cribado de los resultados en las pruebas. Las estadísticas se presentan como media y valores estándar. Resultados: Se evidenció la correlación entre el centro de gravedad de los golfistas en el golpeo y la velocidad de movimiento en el balanceo. La velocidad obtenida por la raqueta en el momento de golpear la pelota está relacionada con el ángulo de inversión de la cadera del golfista. Conclusión: Un centro de gravedad corporal más bajo es beneficioso para mejorar la eficiencia del balanceo de golf. Mantener el cuerpo en equilibrio es clave para dominar el golpe y la aceleración de la raqueta. Cuando el atleta realiza el tirón inverso, la energía que recibe también aumenta, lo que pone de manifiesto la necesidad de un entrenamiento específico para favorecer el equilibrio corporal del atleta. Nivel de evidencia II; Estudios terapéuticos - investigación de los resultados del tratamiento.

16.
Front Aging Neurosci ; 14: 976316, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36408101

RESUMEN

Non-motor symptoms (NMS) of Parkinson's disease (PD), such as constipation, sleep disorders, and olfactory deficits, may emerge up to 20 years earlier than motor symptoms. A series of evidence indicates that the pathology of PD may occur from the gastrointestinal tract to the brain. Numerous studies support that the gut microbiota communicates with the brain through the immune system, special amino acid metabolism, and the nervous system in PD. Recently, there is growing recognition that the gut microbiota plays a vital role in the modulation of multiple neurochemical pathways via the "gut microbiota-brain axis" (GMBA). Many gut microbiota metabolites, such as fatty acids, amino acids, and bile acids, convey signaling functions as they mediate the crosstalk between gut microbiota and host physiology. Amino acids' abundance and species alteration, including glutamate and tryptophan, may disturb the signaling transmission between nerve cells and disrupt the normal basal ganglia function in PD. Specific amino acids and their receptors are considered new potential targets for ameliorating PD. The present study aimed to systematically summarize all available evidence on the gut microbiota-derived amino acid metabolism alterations associated with PD.

17.
Microbiol Spectr ; 10(6): e0324222, 2022 12 21.
Artículo en Inglés | MEDLINE | ID: mdl-36409145

RESUMEN

Cholestasis is characterized by bile acid (BA) circulation disorders, which is usually related to damage of hepatocyte barrier function. Currently, patients with cholestasis face several obstacles in seeking diagnosis and therapy. Da-Huang-Xiao-Shi decoction (DHXSD) is an ancient classic formula that has been used clinically for cholestasis treatment. Nevertheless, the underlying biological activities and therapeutic mechanisms remain unclear. In this study, an alpha-naphthylisothiocyanate (ANIT)-induced cholestasis rat model was established to examine the anticholestatic effects of DHXSD using histopathological and molecular analyses. Transcriptomic analysis combined with 16S rRNA gene sequencing analysis was systematically applied to study the mechanism of action of DHXSD. Simultaneously, the effect of DHXSD on gut microbiota, short-chain fatty acids (SCFAs), and intestinal barrier function were evaluated based on the ANIT-induced cholestasis model in rats. The results showed that DHXSD effectively attenuated ANIT-induced cholestasis by reducing liver function indicators (alanine transaminase [ALT], P < 0.05; alkaline phosphatase [ALP], P < 0.05; total bile acid [TBA], P < 0.01; γ-glutamyl transpeptidase [GGT], P < 0.001) and levels of hepatotoxicity-related enzymes (P < 0.05), thus improving the recovery of histopathological injuries, and regulating levels of inflammatory cytokines (P < 0.05). In addition, 16S rRNA gene sequencing analysis combined with intestinal barrier function analysis revealed that the DHXSD significantly ameliorated ANIT-induced gut microbiota dysbiosis. Significantly altered genes in the model and treatment groups were screened using transcriptomic analysis. Sixty-eight genes and four microbial genera were simultaneously altered with opposing trends in variation after ANIT and DHXSD treatments. We built a framework for predicting targets and host-microbe interaction mechanisms, as well as identifying alternative treatment for cholestasis, which should be validated further for clinical application. In conclusion, DHXSD appears to be a promising agent for protection against liver injury. IMPORTANCE Cholestasis is a serious manifestation of liver diseases resulting in liver injury, fibrosis, and liver failure with limited therapies. To date, only ursodeoxycholic acid (UDCA) has been approved by the U.S. Food and Drug Administration for the treatment of cholestasis. However, approximately one-third of patients with cholestasis are unresponsive to UDCA. Therefore, it is urgent to search for appropriate therapeutic agents for restoring stoppage status of the bile components to treat cholestasis. In this study, we investigated how the microbiome and transcriptome data sets correlated with each other to clarify the role of microbiome alterations in host metabolism. In combination, this research offers potential molecular biomarkers that should be validated for more accurate diagnosis of cholestasis and the clinical utilisation of gut microbiota as a target for treatment.


Asunto(s)
Colestasis , Microbioma Gastrointestinal , Estados Unidos , Ratas , Animales , 1-Naftilisotiocianato/efectos adversos , 1-Naftilisotiocianato/metabolismo , Transcriptoma , ARN Ribosómico 16S/genética , Colestasis/inducido químicamente , Colestasis/tratamiento farmacológico , Colestasis/metabolismo , Hígado , Ácidos y Sales Biliares
18.
Vaccines (Basel) ; 10(11)2022 Nov 09.
Artículo en Inglés | MEDLINE | ID: mdl-36366398

RESUMEN

BACKGROUND: Metabolites are involved in biological process that govern the immune response to infection and vaccination. Knowledge of how metabolites interact with the immune system during immunization with the COVID-19 vaccine is limited. Here, we report that the serum metabolites are correlated with the magnitude of the antibody response in recipients receiving the inactivated COVID-19 vaccine, which provides critical information for studying metabolism regarding the human immune response to vaccination. METHODS: 106 healthy volunteers without history of SARS-CoV-2 infection or vaccination were prospectively enrolled to receive the primary series of two doses of inactivated whole-virion SARS-CoV-2 vaccine. The serum samples were collected 2-4 weeks after the second dose. The magnitude of the anti-RBD antibody was quantified using surrogate virus neutralization tests. The profile of metabolites in serum was identified using untargeted metabolomics analysis. RESULTS: The level of anti-RBD antibody 14-28 days after the second dose was significantly elevated and its interpersonal variability was diverse in a wide range. Thirty-two samples at extremes of the anti-RBD antibody titer were selected to discover the metabolic correlates. Two hundred and fifteen differential metabolites associated with antibody response independent of body mass index were identified. Pregnenolone and sphingolipid metabolism might be involved in the modulation of the human antibody response to the inactivated COVID-19 vaccine. CONCLUSION: We discovered key metabolites as well as those with a related functional significance that might modulate the human immune response to vaccination.

19.
Onco Targets Ther ; 15: 1057-1062, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36186153

RESUMEN

Colonic metastases of lung adenocarcinoma are extremely rare. Signet ring cell adenocarcinoma (SRCA) has not been described in patients with gastrointestinal metastasis of lung adenocarcinoma. SRCA is a unique subtype of adenocarcinoma with strong invasion and a poor prognosis, and most SRCA found in the lung are due to gastrointestinal metastases. This report describes a rare case of colonic metastasis from primary lung SRCA. A 64-year-old female was admitted to Sun Yat-sen University Cancer Center for feeling of nausea and malaise. Following a positron emission tomography CT (PET-CT) scan, widespread metastases of tumor cells were found in the bilateral lung, liver, bone, and multiple lymph nodes, but there was no evidence of metastasis to the colon. Two months later, the patient received a liver biopsy at Tongji Hospital in Wuhan. Pathology revealed a poorly differentiated adenocarcinoma with SRCA conformation, but immunohistochemical staining did not identify the original source of tumor cells. Considering that SRCA mainly derives from the gastrointestinal tract and that serum gastrointestinal tumor markers were elevated, we performed gastrointestinal endoscopy on the patient. The results showed an isolated polyp in the colon, and the pathology results indicated a poorly differentiated adenocarcinoma that was considered to originate from the lung based on immunohistochemical staining. Meanwhile, genetic tests identified a BRAF V600E mutation. The final diagnosis was colonic metastasis of BRAFV 600E mutated lung SRCA. Considering the positive expression of EGFR in this case, cetuximab was innovatively added to the first-line treatment regime (dabrafenib and trametinib). To date, the patient has received thirty-two weeks of treatment. Interestingly, lung and liver tumors shrank and tumor markers in the blood normalized. Our findings offer valuable diagnostic and therapeutic information for colonic metastasis of BRAFV600E mutant primary lung adenocarcinoma with signet ring cell features.

20.
Ren Fail ; 44(1): 1443-1453, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36017686

RESUMEN

BACKGROUND: Nephrotic syndrome (NS) and nephrotic-range proteinuria (NRP) are uncommon in IgA nephropathy (IgAN), and their clinicopathology and prognosis have not been discussed. Podocytes may play an important role in both clinical phenotypes. METHODS: We investigated 119 biopsy-proven IgAN patients with proteinuria over 2 g/d. The patients were divided into three groups according to proteinuria level: the overt proteinuria (OP) group, NS group, and NRP group. In addition, according to the severity of foot process effacement (FPE), the patients were divided into three groups: the segmental FPE (SFPE) group, moderate FPE (MFPE) group, and diffuse FPE (DFPE) group. The outcome was survival from a combined event defined by a doubling of the baseline serum creatinine and a 50% reduction in eGFR or ESRD. RESULTS: Compared with the NRP group, patients in the NS group had more severe microscopic hematuria, presented with more severe endocapillary hypercellularity and had a higher percentage of DFPE. The Kaplan-Meier curve showed that MFPE patients had a better outcome in the NRP group <50% of tubular atrophy/interstitial fibrosis. In the multivariate model, the NRP group (HR = 17.098, 95% CI = 3.835-76.224) was associated with an increased risk of the combined event, while MFPE (HR = 0.260, 95% CI = 0.078-0.864; p = 0.028) was associated with a reduced risk of the combined event. After the addition of renin-angiotensin system inhibitors (RASi), the incidence of the combined event in the MFPE group (HR = 0.179, 95% CI = 0.047-0.689; p = 0.012) was further reduced. CONCLUSIONS: NS presented more active lesions and more severe FPE in IgAN. NRP was an independent risk factor for progression to the renal endpoint, while MFPE indicated a better prognosis in NRP without obvious chronic renal lesions, which may benefit from RASi.


Asunto(s)
Glomerulonefritis por IGA , Síndrome Nefrótico , Podocitos , Glomerulonefritis por IGA/complicaciones , Glomerulonefritis por IGA/tratamiento farmacológico , Glomerulonefritis por IGA/patología , Humanos , Riñón/patología , Síndrome Nefrótico/complicaciones , Síndrome Nefrótico/etiología , Podocitos/patología , Proteinuria/patología , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA